Clinical Trials Directory

Trials / Completed

CompletedNCT05986942

Evaluation of the Postoperative Agitation Prevention and Analgesic Efficacy of Perioperative Dexmedetomidine Infusion in a Pediatric Patient Group to Undergo Tonsillectomy and Adenoidectomy

Status
Completed
Phase
Study type
Observational
Enrollment
80 (actual)
Sponsor
Burak Omur · Academic / Other
Sex
All
Age
2 Years – 10 Years
Healthy volunteers
Not accepted

Summary

Dexmedetomidine is a drug known for its pain-relieving and restlessness-reducing effects. The purpose of this run is to use the association between this use during surgery and the attrition of post-operative pain and discomfort. In the research, laboratory and monitoring results will be obtained before, during and after the operation. Postoperative patient complaints will be evaluated at the postoperative service visit. This study is decided on a completely voluntary basis.

Conditions

Interventions

TypeNameDescription
DRUGFentanylIn Group dex, dexmedetomidine infusion will be administered to the patient during the operation. Fentanyl bolus dose will be administered during anesthesia induction in group Fen.
DRUGDexmedetomidineIn Group dex, dexmedetomidine infusion will be administered to the patient during the operation. Fentanyl bolus dose will be administered during anesthesia induction in group Fen.

Timeline

Start date
2023-10-09
Primary completion
2023-11-07
Completion
2023-11-07
First posted
2023-08-14
Last updated
2023-11-08

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT05986942. Inclusion in this directory is not an endorsement.